Specifically, FDP alleviated liver fibrosis by reducing the levels of COL/A, TGF-β, α-SMA, and MMP-2 in FFC diet-induced MASLD mice. Here, ACTA1 is linked to metabolic dysfunction-associated steatotic liver disease.